Opes Acquisition Corp. Files Definitive Proxy to Extend
by Kristi Marvin on 2019-09-04 at 6:22pm

Opes Acquisition Corp. (OPES), a Mexico-focused SPAC, filed their definitive proxy tonight ahead of their shareholder vote to extend their completion deadline, scheduled for Monday, September 16th. Previously, OPES had filed their preliminary proxy back on August 23rd, but there were a number of blanks throughout that document.  Now that we have additional information, we have a (slightly) clearer picture.

First up, Opes is only asking for a two-month extension to November 15th.  Not three months, not six months, but only two short months. When you ask for a short extension WITHOUT an announced deal, well, that generally means they’re probably going to announce something ASAP.  However, even if they announce something tomorrow, closing a transaction in two months time is very aggressive.  So it’s still a bit curious.  Why not just ask for three months and give the SPAC some breathing room to close?  Or, could it be that they don’t have a deal yet and they decided that if they can’t lock something up within the next two months, they’d rather throw in the towel?  The former is more likely, but still….that two months is odd.  It’s like trying to finish a jigsaw puzzle and you can’t find the last missing piece.

However, Opes isn’t taking any chances with their cash in trust by providing a straight contribution to trust for shareholders who do not redeem with the contribution being $0.0333 per share per month.  The current estimated redemption value is $10.34 with a trust value of approximately $119 million, but if OPES needs the full two months (which they should), that extra $0.0666 brings it to $10.41 + interest, or approximately $10.43.

In summary, this should be a fairly straightforward extension vote with a minimal amount of redemptions.  However, if OPES doesn’t announce a deal by at least the week after their vote (September 16th), they’re either going to have to extend again or liquidate.  Let’s hope we get some good news.

For reference, the Record Date is August 28th, with a redemption deadline of September 12th.

Opes Acquisition Corp. Files Definitive Proxy to Extend
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 7:51pm

Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....

by Nicholas Alan Clayton on 2025-07-01 at 7:47pm

Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....

by Nicholas Alan Clayton on 2025-07-01 at 7:19pm

1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...

by Nicholas Alan Clayton on 2025-07-01 at 3:49pm

D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...

by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved